Analyst Timothy Chiang works at CAPITAL ONE and is covering the the Healthcare sector with 137 price targets and ratings documented since 2015 spanning on 9 stocks. Previously, Timothy Chiang worked at BTIG.
Timothy Chiang's average stock forecast success ratio is 29.02% with an average time for price targets to be met of 98 days.
Most recent stock forecast was given on IRWD, Ironwood Pharmaceuticals, Inc at 02-Sep-2022.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS, INC).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS, INC) at 6/15/2018. The price target of $120 was fulfilled within 4 days with a profit of $17.71 (17.31%) receiving and performance score of 43.28.
Average potential price target upside
Currently, out of the existing stock ratings of Timothy Chiang - 5 which are a Buy (50%), 3 which are a Hold (30%), 2 which are a Sell (20%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
44
$-1.91 (-4.16%)
32
22 days ago
4/4 (100%)
$0.39 (2.75%)
98
Buy
40
$-5.91 (-12.87%)
47
7 months 14 days ago
6/7 (85.71%)
$4.94 (24.27%)
354
Buy
44
$-1.91 (-4.16%)
33
10 months 10 days ago
4/4 (100%)
$3.84 (17.45%)
355
Hold
2 years 10 months 30 days ago
2/2 (100%)
$6.16 (43.55%)
729
Hold
21
$-24.91 (-54.26%)
21
3 years 28 days ago
6/6 (100%)
$0.56 (3.12%)
80
